Results 21 to 30 of about 306,401 (253)

Graft-preserving intervention for treatment of heparin-induced thrombocytopenia secondary to a heparin-bonded renal artery bridging stent graft

Annals of Vascular Surgery - Brief Reports and Innovations, 2023
Heparin Induced Thrombocytopenia (HIT) is a well-recognized phenomenon in patients receiving heparin. Scoring systems such as the 4T score along with platelet factor 4 (PF4) testing have improved recognition and clinical improvement is typically observed
C.Y. Maximilian Png, John Schell, Alyssa M. Flores, Walter Dzik, Rebecca K. Leaf, Abhisekh Mohapatra   +5 more
doaj   +1 more source

Rivaroxaban Treatment for Heparin-Induced Thrombocytopenia: A Case Report and a Review of the Current Experience

Case Reports in Hematology, 2020
Heparin-induced thrombocytopenia is a life-threatening complication of exposure to heparin. Heparin-induced thrombocytopenia results from an autoantibody directed against platelet factor 4 in complex with heparin.
Mohamed Aon, Omar Al-Shammari
doaj   +1 more source

Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants

Frontiers in Molecular Biosciences, 2022
Heparan sulfate (HS) acts as a co-receptor of angiotensin-converting enzyme 2 (ACE2) by interacting with severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein (SGP) facilitating host cell entry of SARS-CoV-2 virus ...
Adrianne L. Gelbach, Fuming Zhang, Seok-Joon Kwon, John T. Bates, Andrew P. Farmer, Jonathan S. Dordick, Jonathan S. Dordick, Chunyu Wang, Chunyu Wang, Robert J. Linhardt, Robert J. Linhardt, Robert J. Linhardt   +11 more
doaj   +1 more source

Heparin [PDF]

Reactions Weekly, 2021
  +16 more sources

Our experience of coronary angiography with and without heparin

Indian Heart Journal, 2012
Aim: Coronary angiography is usually done with heparin. Our aim is to see whether it can be done without heparin through femoral route and its effect on local complications.
Goutam Datta, Arup Dasbiswas, Avijit Bannerjee, Biswakesh Majumder, Achyut Sarkar, Dipankar Mukherjee   +5 more
doaj   +1 more source

Heparin-induced thrombocytopenia among patients of a comprehensive cancer center

SAGE Open Medical Case Reports, 2014
Most clinical studies of heparin-induced thrombocytopenia have not included cancer patients who have high risk of thromboembolism, frequent exposure to heparin, and many potential causes of thrombocytopenia other than heparin-induced thrombocytopenia. To
Weixin Wu, Kelly Merriman, Amr Nabaah, Nikhil Seval, Vahid Afshar-Kharghan, Sai-Ching J Yeung   +5 more
doaj   +1 more source

Living kidney transplantation without perioperative anticoagulation therapy for a patient with heparin‐induced thrombocytopenia

IJU Case Reports, 2020
Introduction Heparin‐induced thrombocytopenia is an antibody‐mediated acquired prothrombotic state induced by heparin exposure. The risk of thromboembolic diseases in kidney transplantation with heparin‐induced thrombocytopenia without perioperative ...
Hayato Nishida, Hiroki Fukuhara, Atsushi Yamagishi, Noriyuki Hosoya, Osamu Ichiyanagi, Toshihiko Sakurai, Sei Naito, Takuya Yamanobe, Tomoyuki Kato, Norihiko Tsuchiya   +9 more
doaj   +1 more source

Heparins: A Shift of Paradigm [PDF]

Frontiers in Medicine, 2019
Heparins inhibit the thrombin forming capacity of plasma, i. e., the endogenous thrombin potential (ETP), by their anti-thrombin (aIIa) activity, the anti-factor Xa (aXa) activity is of minimal importance. This holds for both unfractionated heparin (UFH) and low molecular weight heparin (LMWH) at aXa/aIIa ratios < 25.
Hemker, H. Coenraad, Al Dieri, Raed, Beguin, Suzette   +2 more
openaire   +4 more sources

Understanding heparin-induced thrombosis: A brief review

Medicina Universitaria, 2021
Heparin has been the first line for treatment and prevention of thrombosis for a while. However, one of its non-hemorrhagic effects remains noticeable: heparin-induced thrombocytopenia, mediated by antibodies directed to complexes of platelet factor, and
Mariela Irabien-Zúñiga, Edgar A. Rojas-Guerrero, David Gómez-Almaguer   +2 more
doaj   +1 more source

A heparin-modified thermoresponsive surface with heparin-binding epidermal growth factor-like growth factor for maintaining hepatic functions in vitro and harvesting hepatocyte sheets

Regenerative Therapy, 2016
A heparin-modified thermoresponsive surface bound with heparin-binding epidermal growth factor-like growth factor (HB-EGF) was designed to allow creation of transferrable and functional hepatocyte sheets.
Yoshinori Arisaka, Jun Kobayashi, Kazuo Ohashi, Kohei Tatsumi, Kyungsook Kim, Yoshikatsu Akiyama, Masayuki Yamato, Teruo Okano   +7 more
doaj   +1 more source